Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubha Bansal

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Ocular Immunology and Inflammation|August 13, 2011
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case seriesRitika Sachdev, Shubha Bansal, Rajesh Sinha, et al.
Ophthalmology|September 5, 2013
Author reply: To PMID 23415776Namrata Sharma, Manik Goel, Shubha Bansal, et al.
Ophthalmology|February 19, 2013
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trialNamrata Sharma, Manik Goel, Shubha Bansal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Ocular Immunology and Inflammation|August 13, 2011
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case seriesRitika Sachdev, Shubha Bansal, Rajesh Sinha, et al.
Ophthalmology|September 5, 2013
Author reply: To PMID 23415776Namrata Sharma, Manik Goel, Shubha Bansal, et al.
Ophthalmology|February 19, 2013
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trialNamrata Sharma, Manik Goel, Shubha Bansal, et al.
Pageof 1